Kayo Waki
University of Tokyo
66 Papers
382 Citations
Kayo Waki is an academic researcher from University of Tokyo. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 19, co-authored 60 publications.
Chat about Author
Papers
DialBetics: A Novel Smartphone-based Self-management Support System for Type 2 Diabetes Patients
Kayo Waki,Hideo Fujita,Yuji Uchimura,Koji Omae,Eiji Aramaki,Shigeko Kato,Hanae Lee,Haruka Kobayashi,Takashi Kadowaki,Kazuhiko Ohe +9 more
TL;DR: DialBetics was shown to be a feasible and an effective tool for improving HbA1c by providing patients with real-time support based on their measurements and inputs and BMI improvement-although not statistically significant because of the small sample size-was greater in the DialBetics group.
193
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
David C. Klonoff,Jing Wang,David Rodbard,Michael Kohn,Chengdong Li,Dorian Liepmann,David Kerr,David Ahn,Anne L. Peters,Guillermo E. Umpierrez,Jane Jeffrie Seley,Nicole Y. Xu,Kevin T. Nguyen,Gregg D Simonson,Michael S. D. Agus,Mohammed E. Al-Sofiani,Gustavo Armaiz-Pena,Timothy L. Bailey,Ananda Basu,Tadej Battelino,Sewagegn Yeshiwas Bekele,Pierre-Yves Benhamou,B. Wayne Bequette,Thomas Blevins,Marc D. Breton,Jessica R. Castle,J. Geoffrey Chase,Kong Y. Chen,Pratik Choudhary,Mark A. Clements,Kelly L. Close,Curtiss B. Cook,Thomas Danne,Francis J. Doyle,A. Drincic,Kathleen Dungan,Steven V. Edelman,Niels Ejskjaer,Juan C. Espinoza,G. Alexander Fleming,Gregory P. Forlenza,Guido Freckmann,Rodolfo J. Galindo,Ana María Gómez,Hanna Gutow,Lutz Heinemann,Irl B. Hirsch,Thanh D. Hoang,Roman Hovorka,Johan Jendle,Li Jin,Shashank R Joshi,Michael Joubert,Suneil K. Koliwad,Rayhan A. Lal,M. Cecilia Lansang,Wei-An Andy Lee,Lalantha Leelarathna,Lawrence A. Leiter,Marcus Lind,Michelle L. Litchman,Julia K. Mader,Katherine Mahoney,Boris Mankovsky,Umesh Masharani,Nestoras Mathioudakis,Alexander Mayorov,Jordan Messler,Joshua Miller,Viswanathan Mohan,James H. Nichols,Kirsten Nørgaard,David N O'Neal,Francisco J. Pasquel,Athena Philis-Tsimikas,Thomas R. Pieber,Moshe Phillip,William H. Polonsky,Rodica Pop-Busui,Gerry Rayman,Eun-Jung Rhee,Steven Russell,Viral N. Shah,Jennifer L. Sherr,Koji Sode,Elias K. Spanakis,Deborah J Wake,Kayo Waki,Amisha Wallia,Melissa K. Weinberg,Howard Wolpert,Eugene E. Wright,Mihail Zilbermint,Boris Kovatchev +93 more
TL;DR: The GRI is a single-number summary of the quality of glycemia that provides actionable scores and a graphical display that can be used by clinicians and researchers to determine the glycemic effects of prescribed and investigational treatments.
168
Extraction of adverse drug effects from clinical records.
Eiji Aramaki,Yasuhide Miura,Masatsugu Tonoike,Tomoko Ohkuma,Hiroshi Masuichi,Kayo Waki,Kazuhiko Ohe +6 more
TL;DR: Assessment of how much adverse-effect information is contained in records, and automatic extracting accuracy of the current standard Natural Language Processing (NLP) system revealed that 7.7% of records include adverse event information, and that 59% of them can be extracted automatically.
HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients.
TL;DR: This study supports the position that there is no longer an ethical question surrounding the use of kidneys for HIV-positive patients, and provides studies of kidneys transplanted from the same donor into patients with and without HIV.
87
No Improvement in Long‐Term Liver Transplant Graft Survival in the Last Decade: An Analysis of the UNOS Data
TL;DR: It is concluded that hepatitis C prevented improved outcomes during period II and that improved, more effective, treatment for hepatitis C virus would have great positive impact on overall survival of liver transplant recipients.
82